Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem vs meropenem for complicated urinary tract infection
CTR20170854Phase 3Terminated
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doripenem in complicated urinary tract infection (cUTI), pyelonephritis, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Aug 2017; status: terminated.
02
Drugs
doripenem
03
Conditions
complicated urinary tract infection (cUTI)pyelonephritis
Beyond the preview
Go deeper on CTR20170854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170854.